Clinical trial
New Challenge Pool of Norwalk Virus Inoculum
NCT00138476 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00138476 |
|---|---|
| Title | New Challenge Pool of Norwalk Virus Inoculum |
| Official title | Evaluation of a New Challenge Pool of Norwalk Virus Inoculum (Lot 42399) in Human Subjects |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Gastroenteritis Norovirus |
| Intervention type | Biological, Drug |
| Interventions | Placebo, Norwalk Virus |
| Enrollment | 57 |
| Start date | Aug 1, 2004 |
| Primary completion | Apr 1, 2012 |
| Completion | Sep 1, 2012 |
| First posted | Aug 30, 2005 |
| Last update posted | May 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: